Detalhe da pesquisa
1.
Frequency and characteristics of immune-related thyroid adverse events in patients with resected stage III/IV melanoma treated with adjuvant PD-1 inhibitors: a national cohort study.
Support Care Cancer
; 32(5): 281, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598052